-
1
-
-
0032238156
-
Targeting of anti-cancer drugs with nano-sized carrier system
-
M. Yokoyama, T. Okano, Targeting of anti-cancer drugs with nano-sized carrier system, Jpn. J. Clin. Med. 56 (1998) 3227-3234.
-
(1998)
Jpn. J. Clin. Med.
, vol.56
, pp. 3227-3234
-
-
Yokoyama, M.1
Okano, T.2
-
2
-
-
0031034757
-
Effects of administered route on tissue distribution and antitumor activity of polyethyleneglycol-coated liposomes containing adriamycin
-
Y. Sadzuka, S. Nakai, A. Miyagishima, Y. Nozawa, S. Hirota, Effects of administered route on tissue distribution and antitumor activity of polyethyleneglycol-coated liposomes containing adriamycin, Cancer Lett. 111 (1997) 77-86.
-
(1997)
Cancer Lett.
, vol.111
, pp. 77-86
-
-
Sadzuka, Y.1
Nakai, S.2
Miyagishima, A.3
Nozawa, Y.4
Hirota, S.5
-
3
-
-
0025731906
-
Liposomes containing synthetic lipid derivatives of polyethylene glycol show prolonged circulation half-lives in vivo
-
T.M. Allen, C. Hansen, F. Martin, C. Redemann, A. Yau-Young, Liposomes containing synthetic lipid derivatives of polyethylene glycol show prolonged circulation half-lives in vivo, Biochim. Biophys. Acta 1066 (1991) 29-36.
-
(1991)
Biochim. Biophys. Acta
, vol.1066
, pp. 29-36
-
-
Allen, T.M.1
Hansen, C.2
Martin, F.3
Redemann, C.4
Yau-Young, A.5
-
4
-
-
0032523735
-
Effect of liposomalization on the antitumor activity, side effect and tissue distribution of CPT-11
-
Y. Sadzuka, S. Hirotsu, S. Hirota, Effect of liposomalization on the antitumor activity, side effect and tissue distribution of CPT-11, Cancer Lett. 127 (1998) 99-106.
-
(1998)
Cancer Lett.
, vol.127
, pp. 99-106
-
-
Sadzuka, Y.1
Hirotsu, S.2
Hirota, S.3
-
5
-
-
0033065077
-
Effective irinotecan (CPT-11)-containing liposomes: Intraliposomal conversion to the active metabolite SN-38
-
Y. Sadzuka, S. Hirotsu, S. Hirota, Effective irinotecan (CPT-11)-containing liposomes: intraliposomal conversion to the active metabolite SN-38, Jpn. J. Cancer Res. 90 (1999) 226-232.
-
(1999)
Jpn. J. Cancer Res.
, vol.90
, pp. 226-232
-
-
Sadzuka, Y.1
Hirotsu, S.2
Hirota, S.3
-
6
-
-
0027453162
-
Caffeine modulates the antitumor activity and toxic side effects of adriamycin
-
Y. Sadzuka, E. Mochizuki, Y. Takino, Caffeine modulates the antitumor activity and toxic side effects of adriamycin, Jpn. J. Cancer. Res. 84 (1993) 348-353.
-
(1993)
Jpn. J. Cancer. Res.
, vol.84
, pp. 348-353
-
-
Sadzuka, Y.1
Mochizuki, E.2
Takino, Y.3
-
7
-
-
0028888231
-
Mechanism of caffeine modulation of the antitumor activity of adriamycin
-
Y. Sadzuka, E. Mochizuki, Y. Takino, Mechanism of caffeine modulation of the antitumor activity of adriamycin, Toxicol. Lett. 75 (1995) 39-49.
-
(1995)
Toxicol. Lett.
, vol.75
, pp. 39-49
-
-
Sadzuka, Y.1
Mochizuki, E.2
Takino, Y.3
-
8
-
-
0029022685
-
Effects of methylxanthine derivatives on adriamycin concentration and antitumor activity
-
Y. Sadzuka, A. Iwazaki, A. Miyagishima, Y. Nozawa, S. Hirota, Effects of methylxanthine derivatives on adriamycin concentration and antitumor activity, Jpn. J. Cancer. Res. 86 (1995) 594-599.
-
(1995)
Jpn. J. Cancer. Res.
, vol.86
, pp. 594-599
-
-
Sadzuka, Y.1
Iwazaki, A.2
Miyagishima, A.3
Nozawa, Y.4
Hirota, S.5
-
9
-
-
0031952418
-
1-Methyl-3-propyl-7-butylxanthine, a novel biochemical modulator, enhances therapeutic efficacy of adriamycin
-
Y. Sadzuka, A. Iwazaki, T. Sugiyama, H. Sawanishi, K. Miyamoto, 1-Methyl-3-propyl-7-butylxanthine, a novel biochemical modulator, enhances therapeutic efficacy of adriamycin, Jpn. J. Cancer. Res. 89 (1998) 228-233.
-
(1998)
Jpn. J. Cancer. Res.
, vol.89
, pp. 228-233
-
-
Sadzuka, Y.1
Iwazaki, A.2
Sugiyama, T.3
Sawanishi, H.4
Miyamoto, K.5
-
10
-
-
0030565012
-
The effects of theanine, as a novel biochemical modulator, on the antitumor activity of adriamycin
-
Y. Sadzuka, T. Sugiyama, A. Miyagishima, Y. Nozawa, S. Hirota, The effects of theanine, as a novel biochemical modulator, on the antitumor activity of adriamycin, Cancer Lett. 105 (1996) 203-209.
-
(1996)
Cancer Lett.
, vol.105
, pp. 203-209
-
-
Sadzuka, Y.1
Sugiyama, T.2
Miyagishima, A.3
Nozawa, Y.4
Hirota, S.5
-
12
-
-
0032433184
-
Enhancing effects of green tea components on the antitumor activity of adriamycin against M5076 ovarian sarcoma
-
T. Sugiyama, Y. Sadzuka, Enhancing effects of green tea components on the antitumor activity of adriamycin against M5076 ovarian sarcoma, Cancer Lett. 133 (1998) 19-26.
-
(1998)
Cancer Lett.
, vol.133
, pp. 19-26
-
-
Sugiyama, T.1
Sadzuka, Y.2
-
13
-
-
0033009624
-
Combination of theanine with doxorubicin inhibits hepatic metastasis of M5076 ovarian sarcoma
-
T. Sugiyama, Y. Sadzuka, Combination of theanine with doxorubicin inhibits hepatic metastasis of M5076 ovarian sarcoma, Clin. Cancer Res. 5 (1999) 413-416.
-
(1999)
Clin. Cancer Res.
, vol.5
, pp. 413-416
-
-
Sugiyama, T.1
Sadzuka, Y.2
-
14
-
-
0027195064
-
Antitumor activity of idarubicin, a derivative of daunorubicin, against drug sensitive and resistant P388 leukemia
-
T. Tsuruo, T. Oh-hara, Y. Sudo, M. Naito, Antitumor activity of idarubicin, a derivative of daunorubicin, against drug sensitive and resistant P388 leukemia, Anticancer Res. 13 (1993) 357-362.
-
(1993)
Anticancer Res.
, vol.13
, pp. 357-362
-
-
Tsuruo, T.1
Oh-hara, T.2
Sudo, Y.3
Naito, M.4
-
15
-
-
0027258426
-
Early phase II study of idarubicin, a new anthracycline anticancer drug, in acute leukemia
-
M. Ogawa, T. Masaoka, K. Yamada, K. Kimura, Early phase II study of idarubicin, a new anthracycline anticancer drug, in acute leukemia, Jpn. J. Cancer Chemother. 20 (1993) 897-906.
-
(1993)
Jpn. J. Cancer Chemother.
, vol.20
, pp. 897-906
-
-
Ogawa, M.1
Masaoka, T.2
Yamada, K.3
Kimura, K.4
-
16
-
-
0017075224
-
Adriamycin: Amelioration of toxicity by α-tocopherol
-
C.E. Myers, W.P. McGuire, R.C. Young, Adriamycin: amelioration of toxicity by α-tocopherol, Cancer Treat. Rep. 60 (1976) 961-962.
-
(1976)
Cancer Treat. Rep.
, vol.60
, pp. 961-962
-
-
Myers, C.E.1
McGuire, W.P.2
Young, R.C.3
-
17
-
-
0024842717
-
Effect of adriamycin on the activities of Superoxide dismutase, glutathione peroxidase and catalase in tissues of mice
-
Y. Sadzuka, H. Tanizawa, Y. Takino, Effect of adriamycin on the activities of Superoxide dismutase, glutathione peroxidase and catalase in tissues of mice, Jpn. J. Cancer Res. 80 (1989) 89-94.
-
(1989)
Jpn. J. Cancer Res.
, vol.80
, pp. 89-94
-
-
Sadzuka, Y.1
Tanizawa, H.2
Takino, Y.3
-
18
-
-
0030070072
-
Transport mechanism of anthracycline derivatives in human leukemia cell lines: Uptake and efflux of pirarubicin in HL60 and pirarubicin-resistant HL60 cells
-
K. Nagasawa, T. Natazuka, K. Chihara, F. Kitazawa, A. Tsumura, K. Takara, M. Nomiyama, N. Ohnishi, T. Yokoyama, Transport mechanism of anthracycline derivatives in human leukemia cell lines: uptake and efflux of pirarubicin in HL60 and pirarubicin-resistant HL60 cells, Cancer Chemother. Pharmacol. 37 (1996) 297-304.
-
(1996)
Cancer Chemother. Pharmacol.
, vol.37
, pp. 297-304
-
-
Nagasawa, K.1
Natazuka, T.2
Chihara, K.3
Kitazawa, F.4
Tsumura, A.5
Takara, K.6
Nomiyama, M.7
Ohnishi, N.8
Yokoyama, T.9
-
19
-
-
0030779932
-
Transport mechanism of idarubicin, an anthracycline derivatives, in human leukemia HL60 cells and mononuclear cells, and comparison with those of its analogs
-
K. Nagasawa, N. Ohnishi, T. Yokoyama, Transport mechanism of idarubicin, an anthracycline derivatives, in human leukemia HL60 cells and mononuclear cells, and comparison with those of its analogs, Jpn. J. Cancer Res. 88 (1997) 750-759.
-
(1997)
Jpn. J. Cancer Res.
, vol.88
, pp. 750-759
-
-
Nagasawa, K.1
Ohnishi, N.2
Yokoyama, T.3
-
20
-
-
0031819446
-
Possibility of contribution of nucleoside transport system to pirarubicin uptake by HL60 cells but not mononuclear cells
-
K. Nagasawa, N. Ohnishi, T. Yokoyama, Possibility of contribution of nucleoside transport system to pirarubicin uptake by HL60 cells but not mononuclear cells, Jpn. J. Cancer Res. 89 (1998) 673-680.
-
(1998)
Jpn. J. Cancer Res.
, vol.89
, pp. 673-680
-
-
Nagasawa, K.1
Ohnishi, N.2
Yokoyama, T.3
|